Skip to content

Beta-Blockers in Takotsubo Syndrome: A Randomized Clinical Trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-510213-25-01
Acronym
β-TAKO
Enrollment
200
Registered
2024-03-25
Start date
2024-07-08
Completion date
Unknown
Last updated
2025-03-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Takotsubo Syndrome (TT) is an acute cardiac condition

Brief summary

Comparison of left ventricular systolic function recovery as assessed by the echocardiographic left ventricular wall motion score index (WMSI) at 7 days.

Detailed description

A) Changes in left ventricular function by other methods (LVEF and GLS). B) Comparison of clinical outcomes (adverse clinical events).

Interventions

DRUG-

Sponsors

Fundacion Casa Del Corazon
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
Comparison of left ventricular systolic function recovery as assessed by the echocardiographic left ventricular wall motion score index (WMSI) at 7 days.

Secondary

MeasureTime frame
A) Changes in left ventricular function by other methods (LVEF and GLS). B) Comparison of clinical outcomes (adverse clinical events).

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026